Amanote Research
Register
Sign In
Measuring CD8+ T Cell Tumor Infiltration to Guide Immunotherapy Selection
Science-Business eXchange
doi 10.1038/scibx.2013.1047
Full Text
Open PDF
Abstract
Available in
full text
Date
September 1, 2013
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
Beta-Adrenergic Signaling Impairs Anti-Tumor CD8+ T Cell Responses to B Cell Lymphoma Immunotherapy
Cancer immunology research
Cancer Research
Immunology
Vitamin D Controls Tumor Growth and CD8+ T Cell Infiltration in Breast Cancer
Frontiers in Immunology
Allergy
Immunology
Soluble Γc Receptor Attenuates Anti-Tumor Responses of CD8+ T Cells in T Cell Immunotherapy
International Journal of Cancer
Cancer Research
Oncology
Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8 + T Cells
Cancer Research
Cancer Research
Oncology
OX40 Agonist Immunotherapy Expands Tumor Reactive CD8 T Cells With a Unique T Cell Receptor Repertoire and Synergizes With PDL-1 Blockade to Promote Tumor Regression
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Landscape of Tumor Antigens in T Cell Immunotherapy
Journal of Immunology
Allergy
Immunology
YAP Attenuates CD8 T Cell-Mediated Anti-Tumor Response
Frontiers in Immunology
Allergy
Immunology
Current Advances in Γδ T Cell-Based Tumor Immunotherapy
Frontiers in Immunology
Allergy
Immunology
Precise Spatio-Temporal Interruption of Regulatory T Cell-Mediated CD8+ T Cell Suppression Leads to Tumor Immunity
Cancer Research
Cancer Research
Oncology
